Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/31461| Title: | Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results) | Authors: | Vermersch, P. Eralinna, J. Nicholas, R. Oreja-Guevara, C. Siva, A. VAN WIJMEERSCH, Bart Wiendl, H. Buffels, R. Wei, W. Comi, G. |
Issue Date: | 2020 | Publisher: | SAGE PUBLICATIONS LTD | Source: | MULTIPLE SCLEROSIS JOURNAL, 26 (1_SUPPL) , p. 32 -32 | Document URI: | http://hdl.handle.net/1942/31461 | ISI #: | WOS:000532412600068 | Rights: | 2020 by SAGE Publications. | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| vermersch_2020.pdf Restricted Access | Published version | 107.04 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.